This white paper analyzes how opioid-sparing benefits could help mitigate the risks associated with opioids and argues that the opioid-sparing therapy must not diminish the level of analgesia obtained.
Authors:
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
Christine Moore, PhD
Vice President, Neuroscience, Scientific Solutions
